AMERICAN INTERNATIONAL GROUP, INC. - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$104,159
-22.6%
30,017
+3.7%
0.00%0.0%
Q2 2023$134,618
+12.0%
28,950
+11.3%
0.00%0.0%
Q1 2023$120,203
-41.7%
26,018
+2.0%
0.00%0.0%
Q4 2022$206,040
+59.7%
25,500
+9.8%
0.00%0.0%
Q3 2022$129,000
+20.6%
23,227
+12.7%
0.00%0.0%
Q2 2022$107,000
-39.5%
20,602
-4.3%
0.00%0.0%
Q1 2022$177,000
-48.4%
21,527
-6.6%
0.00%
-50.0%
Q4 2021$343,000
-23.4%
23,042
-2.9%
0.00%0.0%
Q3 2021$448,000
-0.9%
23,732
-2.3%
0.00%0.0%
Q2 2021$452,000
+4.9%
24,296
+28.3%
0.00%0.0%
Q1 2021$431,000
+22.4%
18,943
+16.9%
0.00%
+100.0%
Q4 2020$352,000
+125.6%
16,210
+4.6%
0.00%0.0%
Q3 2020$156,000
+95.0%
15,498
+51.1%
0.00%
Q2 2020$80,000
+21.2%
10,260
+59.3%
0.00%
Q1 2020$66,000
-12.0%
6,440
-5.5%
0.00%
Q4 2019$75,000
+21.0%
6,814
-0.8%
0.00%
Q3 2019$62,000
-21.5%
6,870
-0.7%
0.00%
Q2 2019$79,000
+71.7%
6,918
+69.7%
0.00%
Q1 2019$46,000
+21.1%
4,076
-3.2%
0.00%
Q4 2018$38,0004,2090.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders